CAS: 153502-27-3; O-(2-(Trimethylsilyl)Ethyl)Hydroxylamine Hydrochloride

该化合物是一种化学化合物,其特点是其独特的结构,包括三甲基硅基化合物,乙基链和氢氧基胺功能组;该化合物通常以盐酸盐形式出现,在极溶剂中溶解性增强;该化合物经常用于有机合成,特别是在有机硅化学领域,该化合物是各种转化的试剂,包括保护氨和将硅功能引入有机分子;氢氧胺组的存在允许在形成氧化物和减少碳基化合物中潜在应用;此外,三甲基硅基化合物组可以提供稳定性,增强化合物的挥发性,使其在气色学中有用;安全数据表明,与许多有机硅化合物一样,应谨慎处理该化合物,因为它可能构成风险,如接触时的刺激或毒性.在与该物质打交道时,适当的实验室做法和安全议定书至关重要.

结构式图片

合成工艺路线路线简述

    专利信息


    专利号:US-6458822-B2
    优先权日:2000-03-13
    标题 :2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
    发明人:ROBINSON RALPH P; LAIRD ELLEN R
    权利人:PFIZER
    摘要:The present invention relates to a compound of the formula n wherein R 1 , R 2 , R 3 and R 4 are as defined above, and pharmaceutically acceptable salts and solvates thereof, that are useful, for example, as matrix metalloproteinase inhibitors. The present invention is also directed to pharmaceutical compositions comprising such compounds and methods of treatment for diseases such as osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, tissue ulceration, restinosis, periodontal disease, inflammation, epidermolysis bullosa, scleritis, stroke, Alzheimer's disease, and the like, characterized by inappropriate matrix metalloproteinase activity. Processes for the synthesis of compounds of formula (I) are also disclosed.
    郑州今斯孚化学有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.kingsfine.com/index.html
    电话: 0371-56632527 13838252817👤
    📞郑州今斯孚化学有限公司 ⚠️参考联系方式

    销售电话:0371-56632527 13838252817
    邮箱:sales@kingsfine.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:2-Oxo-Imidazolidine-4-Carboxylic Acid Hydroxamide Compounds That Inhibit Matrix Metalloproteinases
    摘要:The Present Invention Relates To A Compound Of The Formula 1 Wherein R 1 , R 2 , R 3 And R 4 Are As Defined Above, And Pharmaceutically Acceptable Salts And Solvates Thereof, That Are Useful, For Example, As Matrix Metalloproteinase Inhibitors. The Present Invention Is Also Directed To Pharmaceutical Compositions Comprising Such Compounds And Methods Of Treatment For Diseases Such As Osteoarthritis, Rheumatoid Arthritis, Cancer, Osteoporosis, Tissue Ulceration, Restinosis, Periodontal Disease, Inflammation, Epidermolysis Bullosa, Scleritis, Stroke, Alzheimer'S Disease, And The Like, Characterized By Inappropriate Matrix Metalloproteinase Activity. Processes For The Synthesis Of Compounds Of Formula (I) Are Also Disclosed.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知